181 related articles for article (PubMed ID: 15199655)
1. [Effectiveness and tolerability of amisulpride in patients with schizophrenia: results of a 6-month open study].
Rzewuska M; Kuczyński W; Luks M
Psychiatr Pol; 2004; 38(3):453-68. PubMed ID: 15199655
[TBL] [Abstract][Full Text] [Related]
2. [Evaluation of efficacy and tolerance of amisulpride in treatment of schizophrenic psychoses].
Chabannes JP; Pelissolo A; Farah S; Gerard D
Encephale; 1998; 24(4):386-92. PubMed ID: 9809244
[TBL] [Abstract][Full Text] [Related]
3. The effects of amisulpride on five dimensions of psychopathology in patients with schizophrenia: a prospective open-label study.
Herrera-Estrella M; Apiquian R; Fresan A; Sanchez-Torres I
BMC Psychiatry; 2005 May; 5():22. PubMed ID: 15869707
[TBL] [Abstract][Full Text] [Related]
4. A 6-week, randomized, multicentre, open-label study comparing efficacy and tolerability of amisulpride at a starting dose of 400 mg/day versus 800 mg/day in patients with acute exacerbations of schizophrenia.
Lee SJ; Lee JH; Jung SW; Koo BH; Choi TY; Lee KH
Clin Drug Investig; 2012 Nov; 32(11):735-45. PubMed ID: 23018281
[TBL] [Abstract][Full Text] [Related]
5. Amisulpride, and atypical antipsychotic, in the treatment of acute episodes of schizophrenia: a dose-ranging study vs. haloperidol. The Amisulpride Study Group.
Puech A; Fleurot O; Rein W
Acta Psychiatr Scand; 1998 Jul; 98(1):65-72. PubMed ID: 9696517
[TBL] [Abstract][Full Text] [Related]
6. Ziprasidone and amisulpride effectively treat negative symptoms of schizophrenia: results of a 12-week, double-blind study.
Olié JP; Spina E; Murray S; Yang R
Int Clin Psychopharmacol; 2006 May; 21(3):143-51. PubMed ID: 16528136
[TBL] [Abstract][Full Text] [Related]
7. Clinical advantages of amisulpride in the treatment of acute schizophrenia.
Burns T; Bale R
J Int Med Res; 2001; 29(6):451-66. PubMed ID: 11803729
[TBL] [Abstract][Full Text] [Related]
8. Amisulpride versus olanzapine in the treatment of schizophrenia in Indian patients: randomized controlled trial.
Bhowmick S; Hazra A; Ghosh M
Aust N Z J Psychiatry; 2010 Mar; 44(3):237-42. PubMed ID: 20050717
[TBL] [Abstract][Full Text] [Related]
9. Improvement of schizophrenic patients with primary negative symptoms treated with amisulpride. Amisulpride Study Group.
Danion JM; Rein W; Fleurot O
Am J Psychiatry; 1999 Apr; 156(4):610-6. PubMed ID: 10200742
[TBL] [Abstract][Full Text] [Related]
10. Amisulpride compared with standard neuroleptics in acute exacerbations of schizophrenia: three efficacy studies.
Freeman HL
Int Clin Psychopharmacol; 1997 May; 12 Suppl 2():S11-7. PubMed ID: 9218163
[TBL] [Abstract][Full Text] [Related]
11. Combined use of amisulpride and clozapine for patients with treatment-resistant schizophrenia.
Cook B; Hoogenboom G
Australas Psychiatry; 2004 Mar; 12(1):74-6. PubMed ID: 15715745
[TBL] [Abstract][Full Text] [Related]
12. Amisulpride: a review of its use in the management of schizophrenia.
McKeage K; Plosker GL
CNS Drugs; 2004; 18(13):933-56. PubMed ID: 15521794
[TBL] [Abstract][Full Text] [Related]
13. Clinical update on amisulpride in deficit schizophrenia.
Rein W; Turjanski S
Int Clin Psychopharmacol; 1997 May; 12 Suppl 2():S19-27. PubMed ID: 9218164
[TBL] [Abstract][Full Text] [Related]
14. Comparison of clozapine-amisulpride and clozapine-quetiapine combinations for patients with schizophrenia who are partially responsive to clozapine: a single-blind randomized study.
Genç Y; Taner E; Candansayar S
Adv Ther; 2007; 24(1):1-13. PubMed ID: 17526456
[TBL] [Abstract][Full Text] [Related]
15. The acute and long-term effectiveness of amisulpride in patients with schizophrenia: results of a 12-month open-label prospective follow-up study.
Ahn YM; Lee KY; Kim CE; Kang DY; Seok JH; Shin YM; Chung IW; Jun TY; Chang JS; Kim YS
Hum Psychopharmacol; 2011 Dec; 26(8):568-77. PubMed ID: 22139601
[TBL] [Abstract][Full Text] [Related]
16. [Treatment of negative symptoms in schizophrenia by amisulpride. Review of the literature].
Pélissolo A; Krebs MO; Olié JP
Encephale; 1996; 22(3):215-9. PubMed ID: 8767050
[TBL] [Abstract][Full Text] [Related]
17. Amisulpride: a review of its efficacy in schizophrenia.
Möller HJ
Acta Psychiatr Scand Suppl; 2000; 400():17-22. PubMed ID: 10823307
[TBL] [Abstract][Full Text] [Related]
18. Amisulpride: progress and outcomes.
Lecrubier Y
Curr Med Res Opin; 2002; 18 Suppl 3():s18-22. PubMed ID: 12418608
[TBL] [Abstract][Full Text] [Related]
19. Antipsychotic combination using low-dose antipsychotics is as efficacious and safe as, but cheaper, than optimal-dose monotherapy in the treatment of schizophrenia: a randomized, double-blind study.
Lin CH; Wang FC; Lin SC; Huang YH; Chen CC; Lane HY
Int Clin Psychopharmacol; 2013 Sep; 28(5):267-74. PubMed ID: 23778382
[TBL] [Abstract][Full Text] [Related]
20. Amisulpride: efficacy in the management of chronic patients with predominant negative symptoms of schizophrenia.
Möller HJ
Eur Arch Psychiatry Clin Neurosci; 2001 Oct; 251(5):217-24. PubMed ID: 11829208
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
